Spiolto Respimat improves patient outcomes in COPD

New data reinforces benefits of Spiolto ® Respimat® in improving patient outcomesData supports the efficacy and safety profile of Spiolto ®Respimat®1Results from one study emphasise patient satisfaction and ease-of-use with Respimat ® inhaler2Two formative usability studies underscore the patient-centric design and enhanced usability of Respimat ® re-usable inhaler3
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news